New Study Shows That Moderate Exercise Can Enhance Survival in Colorectal Cancer

Experts from Dana-Farber Cancer Institute carried out research to show how low-intensity exercises affect survivability among cancer patients.

Published in the Journal of Oncology, the study shows that even low-intensity exercises like walking for at least four hours a week could lead to almost 20% reduction in the progression of cancer or death.

Metastatic colorectal cancer patients who exercised moderately while on going through chemotherapy had a delayed progression of the cancer. The treatment side effects were also less severe in such patients.

About the Study

·         The study showed that physically active patients had better tolerance towards chemotherapy.
·         At least 30 minutes of moderate physical activity daily was associated with 27% decline in severe toxicities related to treatment.
·         Previous research has revealed that exercising regularly can lower the risk of colon cancer recurrence and death, especially when the cancer has not spread to other areas in the body.
·         Within one month of starting treatment, colorectal cancer patients completed a questionnaire regarding their physical activity for the previous two months. A total of 1,218 patients participated in the study.
·         The researchers said that, although the data are important, validating the results requires further research with a randomized perspective.

Quantifying Physical Activity

Based on the descriptions of patients, the researchers quantified the physical activity using metabolic equivalent task (MET) hours a week. MET-hours are the standard measure commonly used in exercise research studies.

The researchers defined vigorous exercise as any activity that needs six METs or more. Examples of such exercises include:

·         Running
·         Skiing
·         Lap swimming
·         Tennis
·         Biking

Non-vigorous activities, on the other hand, include:

·         Walking
·         Yoga
·         Climbing stairs

Conclusions from Data Analysis

·         Analyzing the data showed a statistically important difference in PFS – the duration after a patient filled the questionnaire before the colorectal cancer advanced or the person died.
·         The PFS difference was about 20% in favor of patients who exercised more.
·         Patience that cloaked at least 18 MET-hours of weekly activity had a 15% higher survival than those who had less than three MET-hours a week.

But the difference didn’t have statistical significance, which shows it may have been a result of chance.
Location: Decatur, TX 76234, USA

Comments

Post a Comment

Popular posts from this blog

Genetic Testing May Improve Chemotherapy for Aggressive Form of Breast Cancer

A study conducted found that an aggressive form of breast cancer , especially when the patient has BRCA mutations, responds well to non-standard chemotherapy. New research suggests that chemotherapy can be improved and personalized with genetic testing for breast cancer. Patients who have triple-negative breast cancer do not respond to the target drug Herceptin or hormone therapies. Therefore they are treated with a chemotherapy agent known as docetaxel. New trial findings indicate that patients with defective versions of BRCA 1 or BRCA 2 are likely to be treated with a different chemo drug known as carboplatin. The results of the finding may change the international guidelines by introducing the genetic testing for triple-negative breast cancer in women. • The trial suggests that most women with triple negative breast cancer can now be considered for testing for BRCA gene faults to enable those who test positive to use carboplatin. • Using the test will greatly help in guidi...
Read more

Do Breast Cancer Therapies Increase the Risk of Heart-Related Deaths?

Breast cancer survival rates have improved over time, but the adverse outcomes of treatment to the heart remain a concern. A U.S.-based registry study shows that although treatments for breast cancer can cause damage to the heart, the patients who undergo chemotherapy or radiotherapy are not likely to die of heart disease. Regular screenings and proper risk management for heart issues in patients with breast cancer can reduce the risk of heart diseases. According to clinical trials conducted before, both radiotherapy and chemotherapy are associated with the risk of heart disease as a possible side effect. However, after the analysis of about 350,000 breast cancer patients relative to the population across the U.S., the comparison showed that long-term risk of death from heart disease is not high compared with the average population of women. This concluded that: • Proper risk management in hospitals, if taken into account when choosing adequate therapy, can reduce the probabili...
Read more

North Texas Oncology: What Patients Can Expect

Receiving a diagnosis of cancer is not something anyone can really be prepared for. For an estimated 1.7 million Americans, this will become a reality in the coming year. Many of those diagnosed will find themselves working with a north Texas oncology provider to battle this disease. While the specifics of treatment will depend on each individual case, patients who select reputable providers can expect several things as they go through treatments. Regardless of diagnosis, prognosis and treatment recommendations, reputable north Texas oncology providers will make sure their patients can expect: • Access to the most appropriate treatments – Cancer treatments are not one-size-fits-all . With that in mind, oncologists strive to help patients explore and select the most appropriate treatment in their unique cases. Reputable providers will help patients explore all viable options. Oncologists associated with larger cancer centers may even be able to provide patients access to cutting-...
Read more